Institutional investors purchased a net $1.8 million shares of DEPO during the quarter ended September 2015 and now own 104.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OXFORD ASSET MANAGEMENT LLP Bought 1.0 Million shares of Depomed Inc
OAK RIDGE INVESTMENTS LLC Bought 745.6 Thousand shares of Depomed Inc
PENN CAPITAL MANAGEMENT CO., INC... Bought 398.9 Thousand shares of Depomed Inc